Menu Search
Equities

Medinice SA

ICE:WSE

Medinice SA

Actions
Health CareMedical Equipment and Services
  • Price (PLN)9.75
  • Today's Change0.25 / 2.63%
  • Shares traded33.13k
  • 1 Year change-0.91%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in PLNIncome statement in PLNView more

Year on year Medinice SA's revenues fell -10.71% from 252.00k to 225.00k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 4.86m to a larger loss of 5.07m.
Gross margin36.65%
Net profit margin-2,145.25%
Operating margin-2,409.50%
Return on assets-12.45%
Return on equity-14.21%
Return on investment-12.78%
More ▼

Cash flow in PLNView more

In 2023, cash reserves at Medinice SA fell by 10.87m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 3.45m for operations while cash used for investing totalled 6.73m.
Cash flow per share-0.7013
Price/Cash flow per share--
Book value per share4.85
Tangible book value per share1.35
More ▼

Balance sheet in PLNView more

Medinice SA has little financial risk as the capital structure does not rely on leverage.
Current ratio4.49
Quick ratio--
Total debt/total equity0.0194
Total debt/total capital0.0191
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.